Swedish Orphan Biovitrum research and development expenses for the twelve months ending September 30, 2024 were $0.324B, a 33.66% increase year-over-year.
Swedish Orphan Biovitrum annual research and development expenses for 2024 were $0.335B, a 26.94% increase from 2023.
Swedish Orphan Biovitrum annual research and development expenses for 2023 were $0.264B, a 13.02% increase from 2022.
Swedish Orphan Biovitrum annual research and development expenses for 2022 were $0.233B, a 0.34% increase from 2021.
Swedish Orphan Biovitrum Research and Development Expenses 2019-2024 | BIOVF